Ratiopharm Ulm
| Player | PTS | REB | AST | MIN | 2M-2A | 3M-3A | FG% | 1M-1A | FT% | OR | DR | STL | BLK | TO | EFF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 7 | 2 | 29 | 1-4 | 3-6 | 40.0% | 8-8 | 100.0% | 3 | 4 | 0 | 0 | 2 | ||
| 13 | 4 | 5 | 27 | 3-4 | 1-2 | 66.7% | 4-6 | 66.7% | 0 | 4 | 1 | 0 | 3 | ||
| 10 | 3 | 1 | 25 | 3-7 | 0-1 | 37.5% | 4-5 | 80.0% | 2 | 1 | 3 | 0 | 1 | ||
| 8 | 1 | 0 | 23 | 0-2 | 1-2 | 25.0% | 5-6 | 83.3% | 0 | 1 | 0 | 0 | 0 | ||
| 7 | 0 | 0 | 9 | 1-2 | 1-1 | 66.7% | 2-3 | 66.7% | 0 | 0 | 0 | 0 | 1 | ||
| 7 | 2 | 2 | 22 | 0-3 | 1-3 | 16.7% | 4-4 | 100.0% | 0 | 2 | 1 | 0 | 4 | ||
| 5 | 2 | 0 | 28 | 1-2 | 1-3 | 40.0% | 0-0 | - | 1 | 1 | 1 | 1 | 1 | ||
| 4 | 5 | 1 | 9 | 2-2 | 0-0 | 100.0% | 0-2 | 0.0% | 3 | 2 | 0 | 0 | 0 | ||
| 4 | 1 | 3 | 13 | 1-3 | 0-1 | 25.0% | 2-3 | 66.7% | 0 | 1 | 1 | 0 | 2 | ||
| 0 | 1 | 1 | 8 | 0-1 | 0-0 | 0.0% | 0-0 | - | 0 | 1 | 0 | 1 | 0 | ||
| 0 | 1 | 1 | 7 | 0-2 | 0-0 | 0.0% | 0-0 | - | 1 | 0 | 0 | 0 | 0 | ||
|
|
77 | 27 | 16 | 12-32 | 8-19 | 39.2% | 29-37 | 78.4% | 10 | 17 | 7 | 2 | 14 | 0 |
MHP Riesen Ludwigsburg
| Player | PTS | REB | AST | MIN | 2M-2A | 3M-3A | FG% | 1M-1A | FT% | OR | DR | STL | BLK | TO | EFF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 11 | 3 | 36 | 8-11 | 1-5 | 56.3% | 0-0 | - | 2 | 9 | 4 | 0 | 3 | ||
| 16 | 7 | 2 | 19 | 7-10 | 0-2 | 58.3% | 2-2 | 100.0% | 5 | 2 | 0 | 0 | 1 | ||
| 15 | 3 | 1 | 36 | 0-2 | 5-7 | 55.6% | 0-0 | - | 0 | 3 | 1 | 0 | 4 | ||
| 15 | 2 | 4 | 40 | 2-5 | 3-11 | 31.3% | 2-2 | 100.0% | 1 | 1 | 1 | 0 | 2 | ||
| 6 | 9 | 1 | 16 | 1-3 | 0-0 | 33.3% | 4-4 | 100.0% | 6 | 3 | 0 | 0 | 2 | ||
| 5 | 3 | 2 | 13 | 1-2 | 1-1 | 66.7% | 0-0 | - | 1 | 2 | 1 | 3 | 0 | ||
| 4 | 2 | 1 | 11 | 1-4 | 0-5 | 11.1% | 2-2 | 100.0% | 1 | 1 | 0 | 0 | 1 | ||
| 3 | 1 | 1 | 20 | 0-0 | 1-3 | 33.3% | 0-0 | - | 0 | 1 | 0 | 0 | 0 | ||
| 0 | 1 | 0 | 5 | 0-0 | 0-0 | - | 0-0 | - | 0 | 1 | 1 | 0 | 1 | ||
| 0 | 0 | 0 | 4 | 0-0 | 0-0 | - | 0-0 | - | 0 | 0 | 0 | 0 | 2 | ||
|
|
83 | 39 | 15 | 20-37 | 11-34 | 43.7% | 10-10 | 100% | 16 | 23 | 8 | 3 | 16 | 0 |